Face mask inactivating viruses and bacteria

该项目解决了卫生工作者和急诊室人员对可靠、可重复使用的高等级个人防护设备的需求。其具体目的是满足因新冠病毒19大流行而加剧的公众需求。根据英国皇家医师学院的数据，在英国，四分之一的医生因为生病或处于自我隔离状态而失业。在意大利，大多数感染发生在医院急诊室，因为没有戴口罩的人数量和流量都很大。总体而言，感染COVID19的人中有10%是医务工作者。这增加了NHS和其他国家卫生组织的压力，特别是在大流行期间。**特别的创新**是一种口罩，用于预防病毒和细菌。这种口罩的新颖性是由多个不同医学领域的技术诀窍组合而成的。这种口罩不仅能过滤掉有害的病原体，还能使它们失活，使病毒无法致病。这种方法的独特之处在于它结合了两种主要类型个人防护设备的最佳方面：a)基于普通滤镜的口罩--轻便、物有所值，提供可重复使用的型号b)基于SCBA的个人防护设备(例如防护服)--提供最高等级的个人防护，适合在高风险环境中工作目前的发明轻便，同时还提供了增强的保护，如基于SCBA的个人防护设备。本发明解决了基于过滤器的口罩(单链RNA病毒比最高级外科口罩中的过滤器小6-10倍，如N95)和SCBA设备的缺点，这些口罩是一次性使用的，而且特别昂贵。我们的目标群体包括急诊室工作人员、高级护理和紧急医务技术员、疫情期间的全科医生、所有其他医务工作者、急诊室访客。“扩大影响”过程与我们的目标一致，即扩大我们的HFEF防护口罩，以达到特定的市场定位。额外的资金将增加创新的影响和上市速度。我们的主要市场将是英国和美国的A&E员工和全科医生。我们使用无厂房业务模式，使我们能够从较低的资本成本中受益，同时将他们的研发资源集中在终端市场上。我们的团队成员拥有实施Horizon 2020项目的经验，并在业务和战略、市场营销和销售、工程和产品设计以及系列企业家精神方面提供独特的技能组合。

The project addresses the need for reliable, re-usable, high-grade PPE for HCW and people in emergency rooms. The specific aim is to satisfy the public need exacerbated by the COVID19 pandemic. In the U.K., one in four doctors is off work because they are either sick or in self-isolation, according to the Royal College of Physicians. In Italy, most infections occurred in hospital emergency rooms due to the volume & traffic of people without masks. Overall, 10% of those infected with COVID19, were HCWs. This increases the strain on the NHS and other National Health organisations, especially during a pandemic.**The specific innovation** is a face mask for protection against viruses and bacteria. The novelty of the mask is created by a combination of know-how from a number of different medical fields. The mask does not simply filter out harmful pathogens, but also inactivates them, rendering viruses incapable of pathogenesis. The approach is unique in the way it combines the best aspects of the two main types of PPE:a) Common filter based face masks -- light and portable, value for money, offers reusable modelsb) SCBA based PPE (for example hazmat suit) -- offers the highest grade of personal protection, suitable for work in high-risk environmentsThe current invention is light and portable while also offering enhanced protection like SCBA-based PPE. The invention solves the drawbacks of filter-based masks (ssRNA viruses are 6-10X smaller than the filters in the highest grade surgical masks, like N95) and of SCBA equipment, which is single-use and exceptionally expensive.Our target groups include A&E staff, Advanced Paramedic and Emergency Medical Technicians, GPs during an epidemic, all other HCWs, visitors to A&E rooms.“Extension for Impact” process aligns with our goal to scale our HFEF protective mask to reach specific market niches. The additional funding will increases the innovation’s impact and speed to market.Our Primary market will be A&E staff and GPs in the UK and the US. We use the fabless business model allowing us to benefit from lower capital costs while concentrating their research and development resources on the end market. Our team members have experience in implementing Horizon 2020 projects and offer a unique combination of skills in business and strategy, marketing & sales, engineering, and product design, and serial entrepreneurship.